V
Volker K.H. Sonntag
Researcher at St. Joseph's Hospital and Medical Center
Publications - 379
Citations - 21101
Volker K.H. Sonntag is an academic researcher from St. Joseph's Hospital and Medical Center. The author has contributed to research in topics: Spinal cord injury & Fixation (surgical). The author has an hindex of 74, co-authored 379 publications receiving 20158 citations. Previous affiliations of Volker K.H. Sonntag include Barrow Neurological Institute.
Papers
More filters
Journal ArticleDOI
Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial
Michael B. Bracken,Mary Jo Shepard,Theodore R. Holford,Linda Leo-Summers,E. Francois Aldrich,Mahmood Fazl,Michael G. Fehlings,Daniel Herr,Patrick W. Hitchon,Lawrence F. Marshall,Russ P. Nockels,Valentine Pascale,Phanor L. Perot,Joseph M. Piepmeier,Volker K.H. Sonntag,Franklin Wagner,Jack E. Wilberger,H. Richard Winn,Wise Young +18 more
TL;DR: Patients with acute spinal cord injury who receive methylprednisolone within 3 hours of injury should be maintained on the treatment regimen for 24 hours, and patients treated with tirilazad for 48 hours showed motor recovery rates equivalent to patients who received methylpredisonsolone for 24Hours.
Journal ArticleDOI
A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury: Results of the Second National Acute Spinal Cord Injury Study
Michael B. Bracken,Mary Jo Shepard,William F. Collins,Theodore R. Holford,Wise Young,David S. Baskin,Howard M. Eisenberg,Eugene S. Flamm,Linda Leo-Summers,Joseph C. Maroon,Lawrence F. Marshall,Phanor L. Perot,Joseph M. Piepmeier,Volker K.H. Sonntag,Franklin C. Wagner,Jack E. Wilberger,H. R. Winn +16 more
TL;DR: It is concluded that in patients with acute spinal-cord injury, treatment with methylprednisolone in the dose used in this study improves neurologic recovery when the medication is given in the first eight hours.
Journal ArticleDOI
A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury
Mark K. Lyons,Michael D. Partington,Fredric B. Meyer,Gary M. Yarkony,Elliot J. Roth,Moris Senegor,Henry G. Stifel,Margaret R. Brown,Michael B. Bracken,Mary Jo Shepard,William F. Collins,Theodore R. Holford,Wise Young,Joseph M. Piepmeier,Linda Leo-Summers,David S. Baskin,Howard M. Eisenberg,Eugene S. Flamm,Lawrence F. Marshall,Joseph C. Maroon,Jack E. Wilberger,Phanor L. Perot,Volker K.H. Sonntag,Franklin C. Wagner,H. Richard Winn +24 more
TL;DR: Studies in animals indicate that methylprednisolone and naloxone are both potentially beneficial in acute spinal-cord injury, but whether any treatment is clinically effective remains uncertain.
Journal ArticleDOI
Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome
Michael T. Lawton,Randall W. Porter,Joseph E. Heiserman,Ronald Jacobowitz,Volker K.H. Sonntag,Curtis A. Dickman +5 more
TL;DR: This large series of SEH demonstrates that rapid diagnosis and emergency surgical treatment maximize neurological recovery, however, patients with complete neurological lesions or long-standing compression can improve substantially with surgery.
Journal ArticleDOI
Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up: Results of the third National Acute Spinal Cord Injury Randomized Controlled Trial
Michael B. Bracken,Mary Jo Shepard,Theodore R. Holford,Linda Leo-Summers,E. Francois Aldrich,Mahmood Fazl,Michael G. Fehlings,Daniel Herr,Patrick W. Hitchon,Lawrence F. Marshall,Russ P. Nockels,Valentine Pascale,Phanor L. Perot,Joseph M. Piepmeier,Volker K.H. Sonntag,Franklin Wagner,Jack E. Wilberger,H. Richard Winn,Wise Young +18 more
TL;DR: A randomized double-blind clinical trial was conducted to compare neurological and functional recovery and morbidity and mortality rates 1 year after acute spinal cord injury in patients who had received a standard 24-hour methylprednisolone regimen with those in whom an identical MP regimen had been delivered for 48 hours.